AG2R LA Mondiale Gestion D Actifs Acquires 1,500 Shares of Agilent Technologies, Inc. $A

AG2R LA Mondiale Gestion D Actifs lifted its holdings in shares of Agilent Technologies, Inc. (NYSE:A) by 12.2% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 13,792 shares of the medical research company’s stock after acquiring an additional 1,500 shares during the quarter. AG2R LA Mondiale Gestion D Actifs’ holdings in Agilent Technologies were worth $1,628,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. Generation Investment Management LLP grew its stake in Agilent Technologies by 19.8% in the first quarter. Generation Investment Management LLP now owns 4,983,556 shares of the medical research company’s stock worth $582,976,000 after purchasing an additional 824,243 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its stake in Agilent Technologies by 18.7% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 3,836,105 shares of the medical research company’s stock worth $448,748,000 after purchasing an additional 604,124 shares during the period. Mackenzie Financial Corp grew its stake in Agilent Technologies by 141.5% in the first quarter. Mackenzie Financial Corp now owns 935,893 shares of the medical research company’s stock worth $109,481,000 after purchasing an additional 548,344 shares during the period. Woodline Partners LP grew its stake in Agilent Technologies by 681.6% in the first quarter. Woodline Partners LP now owns 522,073 shares of the medical research company’s stock worth $61,072,000 after purchasing an additional 455,276 shares during the period. Finally, Nordea Investment Management AB grew its stake in Agilent Technologies by 16.2% in the second quarter. Nordea Investment Management AB now owns 3,213,748 shares of the medical research company’s stock worth $383,143,000 after purchasing an additional 447,207 shares during the period.

Agilent Technologies Trading Up 0.4%

Agilent Technologies stock opened at $148.03 on Friday. The company has a debt-to-equity ratio of 0.53, a current ratio of 2.25 and a quick ratio of 1.71. Agilent Technologies, Inc. has a one year low of $96.43 and a one year high of $153.84. The stock has a market capitalization of $41.97 billion, a PE ratio of 34.75, a price-to-earnings-growth ratio of 4.83 and a beta of 1.26. The business’s fifty day moving average is $130.39 and its 200 day moving average is $119.34.

Agilent Technologies (NYSE:A) last released its quarterly earnings data on Wednesday, August 27th. The medical research company reported $1.37 EPS for the quarter, meeting the consensus estimate of $1.37. Agilent Technologies had a return on equity of 25.51% and a net margin of 17.97%.The company had revenue of $1.74 billion for the quarter, compared to analysts’ expectations of $1.67 billion. During the same period last year, the firm posted $1.32 earnings per share. Agilent Technologies’s revenue was up 10.1% compared to the same quarter last year. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. On average, sell-side analysts predict that Agilent Technologies, Inc. will post 5.58 EPS for the current year.

Agilent Technologies Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, October 22nd. Investors of record on Tuesday, September 30th were given a dividend of $0.248 per share. The ex-dividend date of this dividend was Tuesday, September 30th. This represents a $0.99 annualized dividend and a dividend yield of 0.7%. Agilent Technologies’s dividend payout ratio (DPR) is 23.24%.

Analyst Ratings Changes

Several brokerages recently weighed in on A. Evercore ISI upped their price target on Agilent Technologies from $128.00 to $140.00 and gave the stock an “in-line” rating in a research note on Tuesday, October 7th. Robert W. Baird upped their price target on Agilent Technologies from $141.00 to $142.00 and gave the stock an “outperform” rating in a research note on Thursday, August 28th. Barclays upped their price target on Agilent Technologies from $125.00 to $150.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 2nd. Rothschild & Co Redburn initiated coverage on Agilent Technologies in a research note on Wednesday, October 8th. They issued a “buy” rating and a $165.00 target price on the stock. Finally, TD Cowen increased their target price on Agilent Technologies from $150.00 to $162.00 and gave the stock a “buy” rating in a research note on Tuesday, October 14th. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and six have assigned a Hold rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $149.62.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.